Carson Wealth (CWM LLC)
KNSA icon

Carson Wealth (CWM LLC)’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.1M Buy
22,913
+2,308
+11% +$102K ﹤0.01% 1484
2025
Q4 		$850K Buy
20,605
+764
+4% +$30.6K ﹤0.01% 1595
2025
Q3 		$770K Sell
19,841
-874
-4% -$28.4K ﹤0.01% 1550
2025
Q2 		$573K Sell
20,715
-1,399
-6% -$35.6K ﹤0.01% 1533
2025
Q1 		$491K Buy
22,114
+19,828
+867% +$408K ﹤0.01% 1447
2024
Q4 		$45K Sell
2,286
-163
-7% -$3.72K ﹤0.01% 2881
2024
Q3 		$61K Buy
2,449
+1,998
+443% +$48.7K ﹤0.01% 2549
2024
Q2 		$8K Buy
451
+311
+222% +$5.83K ﹤0.01% 3671
2024
Q1 		$3K Buy
140
+13
+10% +$254 ﹤0.01% 3853
2023
Q4 		$2K Buy
127
+42
+49% +$690 ﹤0.01% 3813
2023
Q3 		$1K Buy
+85
New +$1.43K ﹤0.01% 4007
2022
Q1 		– Sell
-28
Closed – – 3698
2021
Q4 		$0 Buy
+28
New +$344 ﹤0.01% 3571
2021
Q2 		$1K Hold
55
– – ﹤0.01% 2814
2021
Q1 		$1K Hold
55
– – ﹤0.01% 2814
2020
Q4 		$1K Hold
55
– – ﹤0.01% 2814
2020
Q3 		$1K Hold
55
– – ﹤0.01% 2813
2020
Q2 		$1K Hold
55
– – ﹤0.01% 2813
2020
Q1 		$1K Hold
55
– – ﹤0.01% 2812
2019
Q4 		$1K Hold
55
– – ﹤0.01% 2812
2019
Q3 		$1K Hold
55
– – ﹤0.01% 2812
2019
Q2 		$1K Hold
55
– – ﹤0.01% 2812
2019
Q1 		$1K Buy
+55
New +$1.06K ﹤0.01% 2811

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Carson Wealth (CWM LLC)'s KNSA Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Kiniksa Pharmaceuticals (KNSA) stake by 11% in Q1 2026, buying an estimated $102K and bringing the position to 22,913 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1484.

Carson Wealth (CWM LLC) first reported a position in KNSA in Q1 2019 and has held it in 22 quarters since. 228 funds tracked by Wall St. Rank hold KNSA as of Q1 2026.

  • Carson Wealth (CWM LLC) held 22,913 shares of Kiniksa Pharmaceuticals worth $1.1M as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 2,308 Kiniksa Pharmaceuticals shares in Q1 2026, an estimated $102K.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #1484 holding.
  • Carson Wealth (CWM LLC) first reported a position in Kiniksa Pharmaceuticals in Q1 2019 and has held it in 22 quarters since.
  • 228 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.